{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:09:26Z","timestamp":1760346566919,"version":"3.37.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Consumer Health Products Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10552-016-0818-2","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T11:18:42Z","timestamp":1478776722000},"page":"1411-1418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8929-6204","authenticated-orcid":false,"given":"Noel S.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"key":"818_CR1","volume-title":"Cancer epidemiology and prevention","author":"LA Habel","year":"2006","unstructured":"Habel LA, Friedman GD (2006) Pharmaceuticals other than hormones. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. Oxford, New York"},{"key":"818_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0027-5107(95)00185-9","volume":"349","author":"G Bergman","year":"1996","unstructured":"Bergman G, Muller L, Teigen SW (1996) The genotoxicity and carcinogenicity of paracetamol: a regulatory review. Mutat Res 349:263\u2013288","journal-title":"Mutat Res"},{"key":"818_CR3","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1021\/bi036107r","volume":"43","author":"RP Bender","year":"2004","unstructured":"Bender RP, Lindsey RH, Burden DA, Osheroff N (2004) N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison. Biochemistry 43:3731\u20133739","journal-title":"Biochemistry"},{"key":"818_CR4","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1158\/0008-5472.CAN-05-4253","volume":"66","author":"LA Anderson","year":"2006","unstructured":"Anderson LA, Johnston BT, Watson RG et al (2006) Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res 66:4975\u20134982","journal-title":"Cancer Res"},{"key":"818_CR5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1055-9965.EPI-07-2852","volume":"17","author":"S Sadeghi","year":"2008","unstructured":"Sadeghi S, Bain CJ, Pandeya N, Webb PM, Green AC, Whiteman DC (2008) Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Cancer Epidemiol Biomarkers Prev 17:1169\u20131178","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"818_CR6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001648-200101000-00015","volume":"12","author":"LA Garcia-Rodriguez","year":"2001","unstructured":"Garcia-Rodriguez LA, Huerta-Alvarez C (2001) Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 12:88\u201393","journal-title":"Epidemiology"},{"key":"818_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2407-8-237","volume":"8","author":"RE Harris","year":"2008","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA (2008) Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 8:237","journal-title":"BMC Cancer"},{"key":"818_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1592\/phco.22.5.303.33189","volume":"22","author":"CR Meier","year":"2002","unstructured":"Meier CR, Schmitz S, Jick H (2002) Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy 22:303\u2013309","journal-title":"Pharmacotherapy"},{"key":"818_CR9","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#","volume":"74","author":"JE Muscat","year":"1994","unstructured":"Muscat JE, Stellman SD, Wynder EL (1994) Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 74:1847\u20131854","journal-title":"Cancer"},{"key":"818_CR10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archinte.1994.00420040050009","volume":"154","author":"II Peleg","year":"1994","unstructured":"Peleg II, Maibach HT, Brown SH, Wilcox CM (1994) Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154:394\u2013399","journal-title":"Arch Intern Med"},{"key":"818_CR11","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1158\/1055-9965.EPI-11-0709","volume":"20","author":"RB Walter","year":"2011","unstructured":"Walter RB, Brasky TM, White E (2011) Cancer risk associated with long-term use of acetaminophen in the prospective VITamins and lifestyle (VITAL) study. Cancer Epidemiol Biomarkers Prev. 20:2637\u20132641","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"818_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ijc.1581","volume":"97","author":"S Friis","year":"2002","unstructured":"Friis S, Nielsen GL, Mellemkjaer L et al (2002) Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study. Int J Cancer 97:96\u2013101","journal-title":"Int J Cancer"},{"key":"818_CR13","first-page":"1322","volume":"53","author":"MJ Thun","year":"1993","unstructured":"Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322\u20131327","journal-title":"Cancer Res"},{"key":"818_CR14","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1940-6207.CAPR-11-0146","volume":"4","author":"XL Tan","year":"2011","unstructured":"Tan XL, Reid Lombardo KM, Bamlet WR et al (2011) Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila) 4:1835\u20131841","journal-title":"Cancer Prev Res (Phila)"},{"key":"818_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6604151","volume":"98","author":"JH Olsen","year":"2008","unstructured":"Olsen JH, Friis S, Poulsen AH et al (2008) Use of NSAIDs, smoking and lung cancer risk. Br J Cancer 98:232\u2013237","journal-title":"Br J Cancer"},{"key":"818_CR16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7150\/ijbs.3.328","volume":"3","author":"RE Harris","year":"2007","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA (2007) Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. Int J Biol Sci. 3:328\u2013334","journal-title":"Int J Biol Sci."},{"key":"818_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.breast.2010.07.004","volume":"20","author":"V Ashok","year":"2011","unstructured":"Ashok V, Dash C, Rohan TE, Sprafka JM, Terry PD (2011) Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk. Breast 20:66\u201370","journal-title":"Breast"},{"key":"818_CR18","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10552-011-9832-6","volume":"22","author":"JL Bosco","year":"2011","unstructured":"Bosco JL, Palmer JR, Boggs DA, Hatch EE, Rosenberg L (2011) Regular aspirin use and breast cancer risk in US Black women. Cancer Causes Control 22:1553\u20131561","journal-title":"Cancer Causes Control"},{"key":"818_CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/archinternmed.2008.537","volume":"169","author":"AH Eliassen","year":"2009","unstructured":"Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE (2009) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses\u2019 Health Study II. Arch Intern Med 169:115\u2013121","journal-title":"Arch Intern Med"},{"key":"818_CR20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CEJ.0b013e3282b6fd55","volume":"17","author":"S Friis","year":"2008","unstructured":"Friis S, Thomassen L, Sorensen HT et al (2008) Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev 17:88\u201396","journal-title":"Eur J Cancer Prev"},{"key":"818_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bjc.6602003","volume":"91","author":"LA Garcia-Rodriguez","year":"2004","unstructured":"Garcia-Rodriguez LA, Gonzalez-Perez A (2004) Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 91:525\u2013529","journal-title":"Br J Cancer"},{"key":"818_CR22","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE, Chlebowski RT, Jackson RD et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women\u2019s Health Initiative. Cancer Res 63:6096\u20136101","journal-title":"Cancer Res"},{"key":"818_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-6-27","volume":"6","author":"RE Harris","year":"2006","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA (2006) Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 6:27","journal-title":"BMC Cancer"},{"key":"818_CR24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97:805\u2013812","journal-title":"J Natl Cancer Inst"},{"key":"818_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2407-5-159","volume":"5","author":"E Rahme","year":"2005","unstructured":"Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M (2005) Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 5:159","journal-title":"BMC Cancer"},{"key":"818_CR26","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291:2433\u20132440","journal-title":"JAMA"},{"key":"818_CR27","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1200\/JCO.2012.42.2006","volume":"30","author":"X Zhang","year":"2012","unstructured":"Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE (2012) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol 30:3468\u20133477","journal-title":"J Clin Oncol"},{"key":"818_CR28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/1055-9965.EPI-12-0390-T","volume":"21","author":"VW Setiawan","year":"2012","unstructured":"Setiawan VW, Matsuno RK, Lurie G et al (2012) Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 21:1441\u20131449","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"818_CR29","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1158\/0008-5472.CAN-07-6257","volume":"68","author":"AN Viswanathan","year":"2008","unstructured":"Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE (2008) Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res 68:2507\u20132513","journal-title":"Cancer Res"},{"key":"818_CR30","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/aje\/kwp321","volume":"170","author":"C Bodelon","year":"2009","unstructured":"Bodelon C, Doherty JA, Chen C, Rossing MA, Weiss NS (2009) Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. Am J Epidemiol 170:1512\u20131517","journal-title":"Am J Epidemiol"},{"key":"818_CR31","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1158\/1055-9965.EPI-05-0457","volume":"14","author":"KB Moysich","year":"2005","unstructured":"Moysich KB, Baker JA, Rodabaugh KJ, Villella JA (2005) Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14:2923\u20132928","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"818_CR32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ijc.27717","volume":"132","author":"AS Neill","year":"2013","unstructured":"Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM (2013) Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis. Int J Cancer 132:1146\u20131155","journal-title":"Int J Cancer"},{"key":"818_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djt431","volume":"106","author":"B Trabert","year":"2014","unstructured":"Trabert B, Ness RB, Lo-Ciganic WH et al (2014) Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst 106:1\u201311","journal-title":"J Natl Cancer Inst"},{"key":"818_CR34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.11538","volume":"108","author":"JV Lacey Jr","year":"2004","unstructured":"Lacey JV Jr, Sherman ME, Hartge P, Schatzkin A, Schairer C (2004) Medication use and risk of ovarian carcinoma: a prospective study. Int J Cancer 108:281\u2013286","journal-title":"Int J Cancer"},{"key":"818_CR35","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kwp062","volume":"169","author":"SP Pinheiro","year":"2009","unstructured":"Pinheiro SP, Tworoger SS, Cramer DW, Rosner BA, Hankinson SE (2009) Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts. Am J Epidemiol 169:1378\u20131387","journal-title":"Am J Epidemiol"},{"key":"818_CR36","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0140-6736(05)60745-3","volume":"352","author":"C Rodriguez","year":"1998","unstructured":"Rodriguez C, Henley SJ, Calle EE, Thun MJ (1998) Paracetamol and risk of ovarian cancer mortality in a prospective study of women in the USA. Lancet 352:1354\u20131355","journal-title":"Lancet"},{"key":"818_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju111","author":"L Baandrup","year":"2014","unstructured":"Baandrup L, Friis S, Dehlendorff C, Andersen KK, Olsen JH, Kjaer SK (2014) Prescription use of paracetamol and risk for ovarian cancer in Denmark. J Natl Cancer Inst. doi: 10.1093\/jnci\/dju111","journal-title":"J Natl Cancer Inst"},{"key":"818_CR38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/EDE.0b013e3182456ad3","volume":"23","author":"WH Lo-Ciganic","year":"2012","unstructured":"Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB (2012) Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology 23:311\u2013319","journal-title":"Epidemiology"},{"key":"818_CR39","first-page":"903","volume":"10","author":"KB Moysich","year":"2001","unstructured":"Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H (2001) Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 10:903\u2013906","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"818_CR40","first-page":"933","volume":"9","author":"L Rosenberg","year":"2000","unstructured":"Rosenberg L, Palmer JR, Rao RS et al (2000) A case-control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9:933\u2013937","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"818_CR41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1158\/1055-9965.EPI-11-0210","volume":"20","author":"EJ Jacobs","year":"2011","unstructured":"Jacobs EJ, Newton CC, Stevens VL, Gapstur SM (2011) A large cohort study of long-term acetaminophen use and prostate cancer incidence. Cancer Epidemiol Biomarkers Prev 20:1322\u20131328","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"818_CR42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.649.13.4","volume":"13","author":"LA Garcia-Rodriguez","year":"2004","unstructured":"Garcia-Rodriguez LA, Gonzalez-Perez A (2004) Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev 13:649\u2013653","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"818_CR43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/aje\/kwq175","volume":"172","author":"CA Salinas","year":"2010","unstructured":"Salinas CA, Kwon EM, FitzGerald LM et al (2010) Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. Am J Epidemiol 172:578\u2013590","journal-title":"Am J Epidemiol"},{"key":"818_CR44","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/ijc.25465","volume":"128","author":"AS Murad","year":"2011","unstructured":"Murad AS, Down L, Davey SG et al (2011) Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study). Int J Cancer 128:1442\u20131448","journal-title":"Int J Cancer"},{"key":"818_CR45","first-page":"169","volume":"7","author":"JE Nelson","year":"2000","unstructured":"Nelson JE, Harris RE (2000) Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study. Oncol Rep 7:169\u2013170","journal-title":"Oncol Rep"},{"key":"818_CR46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1158\/1055-9965.EPI-04-0532","volume":"14","author":"EA Platz","year":"2005","unstructured":"Platz EA, Rohrmann S, Pearson JD et al (2005) Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging. Cancer Epidemiol Biomarkers Prev 14:390\u2013396","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"818_CR47","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/bjc.2014.381","volume":"111","author":"T Veitonmaki","year":"2014","unstructured":"Veitonmaki T, Murtola TJ, Maattanen L et al (2014) Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial. Br J Cancer 111:1421\u20131431","journal-title":"Br J Cancer"},{"key":"818_CR48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00001648-199607000-00004","volume":"7","author":"LE Derby","year":"1996","unstructured":"Derby LE, Jick H (1996) Acetaminophen and renal and bladder cancer. Epidemiology 7:358\u2013362","journal-title":"Epidemiology"},{"key":"818_CR49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bjc.6690728","volume":"81","author":"M Gago-Dominguez","year":"1999","unstructured":"Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC (1999) Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer 81:542\u2013548","journal-title":"Br J Cancer"},{"key":"818_CR50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00001648-200111000-00018","volume":"12","author":"JA Kaye","year":"2001","unstructured":"Kaye JA, Myers MW, Jick H (2001) Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiology 12:690\u2013694","journal-title":"Epidemiology"},{"key":"818_CR51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00053150","volume":"4","author":"N Kreiger","year":"1993","unstructured":"Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA (1993) Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 4:101\u2013110","journal-title":"Cancer Causes Control"},{"key":"818_CR52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.2910600312","volume":"60","author":"M McCredie","year":"1995","unstructured":"McCredie M, Pommer W, McLaughlin JK et al (1995) International renal-cell cancer study. II. Analgesics. Int J Cancer 60:345\u2013349","journal-title":"Int J Cancer"},{"key":"818_CR53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1008805505154","volume":"9","author":"L Rosenberg","year":"1998","unstructured":"Rosenberg L, Rao RS, Palmer JR et al (1998) Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States). Cancer Causes Control 9:83\u201388","journal-title":"Cancer Causes Control"},{"key":"818_CR54","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archinternmed.2011.356","volume":"171","author":"E Cho","year":"2011","unstructured":"Cho E, Curhan G, Hankinson SE et al (2011) Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med 171:1487\u20131493","journal-title":"Arch Intern Med"},{"key":"818_CR55","doi-asserted-by":"crossref","first-page":"e70008","DOI":"10.1371\/journal.pone.0070008","volume":"8","author":"H Zhang","year":"2013","unstructured":"Zhang H, Jiang D, Li X (2013) Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies. PLoS ONE 8:e70008","journal-title":"PLoS ONE"},{"key":"818_CR56","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10552-012-0019-6","volume":"23","author":"JM Jeter","year":"2012","unstructured":"Jeter JM, Han J, Martinez ME, Alberts DS, Qureshi AA, Feskanich D (2012) Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses\u2019 Health Study. Cancer Causes Control 23:1451\u20131461","journal-title":"Cancer Causes Control"},{"key":"818_CR57","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/cncr.27817","volume":"119","author":"CA Gamba","year":"2013","unstructured":"Gamba CA, Swetter SM, Stefanick ML et al (2013) Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women\u2019s Health Initiative. Cancer 119:1562\u20131569","journal-title":"Cancer"},{"key":"818_CR58","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaad.2010.05.042","volume":"65","author":"DC Torti","year":"2011","unstructured":"Torti DC, Christensen BC, Storm CA et al (2011) Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study. J Am Acad Dermatol 65:304\u2013312","journal-title":"J Am Acad Dermatol"},{"key":"818_CR59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ypmed.2014.08.024","volume":"69C","author":"A Wysong","year":"2014","unstructured":"Wysong A, Ally MS, Gamba CS et al (2014) Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women\u2019s Health Initiative. Prev Med 69C:8\u201312","journal-title":"Prev Med"},{"key":"818_CR60","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/aje\/kwh153","volume":"159","author":"NR Sivak-Sears","year":"2004","unstructured":"Sivak-Sears NR, Schwartzbaum JA, Miike R, Moghadassi M, Wrensch M (2004) Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme. Am J Epidemiol 159:1131\u20131139","journal-title":"Am J Epidemiol"},{"key":"818_CR61","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1021953224822","volume":"13","author":"I Kato","year":"2002","unstructured":"Kato I, Koenig KL, Shore RE et al (2002) Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin\u2019s lymphoma (NHL) (United States). Cancer Causes Control 13:965\u2013974","journal-title":"Cancer Causes Control"},{"key":"818_CR62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10552-004-3074-9","volume":"16","author":"JA Baker","year":"2005","unstructured":"Baker JA, Weiss JR, Czuczman MS, Menezes RJ, Ambrosone CB, Moysich KB (2005) Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 16:301\u2013308","journal-title":"Cancer Causes Control"},{"key":"818_CR63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/oxfordjournals.aje.a010017","volume":"150","author":"EA Holly","year":"1999","unstructured":"Holly EA, Lele C, Bracci PM, McGrath MS (1999) Case-control study of non-Hodgkin\u2019s lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 150:375\u2013389","journal-title":"Am J Epidemiol"},{"key":"818_CR64","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2011.34.6346","volume":"29","author":"RB Walter","year":"2011","unstructured":"Walter RB, Milano F, Brasky TM, White E (2011) Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study. J Clin Oncol 29:2424\u20132431","journal-title":"J Clin Oncol"},{"key":"818_CR65","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00432-009-0551-2","volume":"135","author":"N Becker","year":"2009","unstructured":"Becker N, Fortuny J, Alvaro T et al (2009) Medical history and risk of lymphoma: results of a European case-control study (EPILYMPH). J Cancer Res Clin Oncol 135:1099\u20131107","journal-title":"J Cancer Res Clin Oncol"},{"key":"818_CR66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jnci\/djh038","volume":"96","author":"ET Chang","year":"2004","unstructured":"Chang ET, Zheng T, Weir EG et al (2004) Aspirin and the risk of Hodgkin\u2019s lymphoma in a population-based case-control study. J Natl Cancer Inst 96:305\u2013315","journal-title":"J Natl Cancer Inst"},{"key":"818_CR67","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.leukres.2006.07.027","volume":"31","author":"KB Moysich","year":"2007","unstructured":"Moysich KB, Bonner MR, Beehler GP et al (2007) Regular analgesic use and risk of multiple myeloma. Leuk Res 31:547\u2013551","journal-title":"Leuk Res"},{"key":"818_CR68","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.leukres.2005.06.023","volume":"30","author":"JR Weiss","year":"2006","unstructured":"Weiss JR, Baker JA, Baer MR, Menezes RJ, Nowell S, Moysich KB (2006) Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia. Leuk Res 30:164\u2013169","journal-title":"Leuk Res"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-016-0818-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T01:00:17Z","timestamp":1657674017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-016-0818-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,10]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s10552-016-0818-2","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2016,11,10]]}}}